Biotech beauty firm Debut announced on Tuesday it has inked $20 million in investment to expand its AI-based ingredient discovery platform and scale its formulation business in the U.S. and Asia.

The San Diego-based company's funding round was lead by Fine Structure Ventures, EDBI, Wealthberry, Bold (the venture fund of L'Oréal ), GS Futures, Sandbox Industries and Material Impact, among others.

Debut said it will use the funding to discover ingredients that target the 14 hallmarks of aging, in turn helping its global beauty partners to innovate with biotech ingredients and formulations.

It will also enable beauty brands to outsource their formulation innovation, at scale and without the upfront R&D expense associated with biotech.

"Debut is laser-focused on staying at the forefront

See Full Page